PHARMACYTE BIOTECH, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
PHARMACYTE BIOTECH, INC. (PMCB) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 9-month period ending 2019-01-31, per its 10-Q filed 2019-03-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2019-03-14
- PHARMACYTE BIOTECH, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2019-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2018-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2018-07-31 was $0.00.
- PHARMACYTE BIOTECH, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2018-01-31 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month |
|---|---|---|---|
| 2019-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-14 | $0.00 10-Q · filed 2019-03-14 |
| 2018-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-14 | $0.00 10-Q · filed 2018-12-14 | |
| 2018-07-31 | $0.00 10-Q · filed 2018-09-12 | ||
| 2018-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-14 | $0.00 10-Q · filed 2019-03-14 |
| 2017-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-14 | $0.00 10-Q · filed 2018-12-14 | |
| 2017-07-31 | $0.00 10-Q · filed 2018-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |